High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia
Open Access
- 24 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 434 (5) , 167402
Abstract
No abstract availableKeywords
Funding Information
- Hyundai Hope On Wheels
- National Cancer Institute (R01 CA194864, R01 CA212608, R01 CA245502, R21 CA246457)
- National Institute of Allergy and Infectious Diseases (R21 AI158997)
- Leukemia and Lymphoma Society
- Biological and Environmental Research (DE-AC02-06CH11357)
- Argonne National Laboratory
- New York University (US 63/174,131)
- U.S. Department of Energy
- National Institutes of Health
This publication has 83 references indexed in Scilit:
- Evolutionarily Conserved Paired Immunoglobulin-like Receptor α (PILRα) Domain Mediates Its Interaction with Diverse Sialylated LigandsJournal of Biological Chemistry, 2012
- Towards automated crystallographic structure refinement with phenix.refineActa Crystallographica Section D Structural Biology, 2012
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- Highly avid magnetic bead capture: An efficient selection method for de novo protein engineering utilizing yeast surface displayBiotechnology Progress, 2009
- γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemiaNature Medicine, 2008
- Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemiaNature Medicine, 2007
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transductionBiochemical Journal, 2005
- [20] Processing of X-ray diffraction data collected in oscillation mode1997